» Articles » PMID: 28546534

Classification of Paediatric Inflammatory Bowel Disease Using Machine Learning

Overview
Journal Sci Rep
Specialty Science
Date 2017 May 27
PMID 28546534
Citations 64
Authors
Affiliations
Soon will be listed here.
Abstract

Paediatric inflammatory bowel disease (PIBD), comprising Crohn's disease (CD), ulcerative colitis (UC) and inflammatory bowel disease unclassified (IBDU) is a complex and multifactorial condition with increasing incidence. An accurate diagnosis of PIBD is necessary for a prompt and effective treatment. This study utilises machine learning (ML) to classify disease using endoscopic and histological data for 287 children diagnosed with PIBD. Data were used to develop, train, test and validate a ML model to classify disease subtype. Unsupervised models revealed overlap of CD/UC with broad clustering but no clear subtype delineation, whereas hierarchical clustering identified four novel subgroups characterised by differing colonic involvement. Three supervised ML models were developed utilising endoscopic data only, histological only and combined endoscopic/histological data yielding classification accuracy of 71.0%, 76.9% and 82.7% respectively. The optimal combined model was tested on a statistically independent cohort of 48 PIBD patients from the same clinic, accurately classifying 83.3% of patients. This study employs mathematical modelling of endoscopic and histological data to aid diagnostic accuracy. While unsupervised modelling categorises patients into four subgroups, supervised approaches confirm the need of both endoscopic and histological evidence for an accurate diagnosis. Overall, this paper provides a blueprint for ML use with clinical data.

Citing Articles

Pathways to chronic disease detection and prediction: Mapping the potential of machine learning to the pathophysiological processes while navigating ethical challenges.

Afrifa-Yamoah E, Adua E, Peprah-Yamoah E, Anto E, Opoku-Yamoah V, Acheampong E Chronic Dis Transl Med. 2025; 11(1):1-21.

PMID: 40051825 PMC: 11880127. DOI: 10.1002/cdt3.137.


Artificial intelligence use for precision medicine in inflammatory bowel disease: a systematic review.

Ceccato H, Silva T, Genaro L, Silva J, de Souza W, Oliveira P Am J Transl Res. 2025; 17(1):28-46.

PMID: 39959235 PMC: 11826164. DOI: 10.62347/XILL3707.


Artificial intelligence: A new tool in the pathologist's armamentarium for the diagnosis of IBD.

Cannarozzi A, Massimino L, Latiano A, Parigi T, Giuliani F, Bossa F Comput Struct Biotechnol J. 2024; 23:3407-3417.

PMID: 39345902 PMC: 11437746. DOI: 10.1016/j.csbj.2024.09.003.


Identifying heterogeneous subgroups of systemic autoimmune diseases by applying a joint dimension reduction and clustering approach to immunomarkers.

Chang C, Wang H, Lin W, Wang Y, Lo W, Lin T BioData Min. 2024; 17(1):36.

PMID: 39285420 PMC: 11403832. DOI: 10.1186/s13040-024-00389-7.


Artificial intelligence and machine learning technologies in ulcerative colitis.

Kulkarni C, Liu D, Fardeen T, Dickson E, Jang H, Sinha S Therap Adv Gastroenterol. 2024; 17:17562848241272001.

PMID: 39247718 PMC: 11378191. DOI: 10.1177/17562848241272001.


References
1.
Kannel W, DOYLE J, MCNAMARA P, Quickenton P, Gordon T . Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation. 1975; 51(4):606-13. DOI: 10.1161/01.cir.51.4.606. View

2.
Wei Z, Wang W, Bradfield J, Li J, Cardinale C, Frackelton E . Large sample size, wide variant spectrum, and advanced machine-learning technique boost risk prediction for inflammatory bowel disease. Am J Hum Genet. 2013; 92(6):1008-12. PMC: 3675261. DOI: 10.1016/j.ajhg.2013.05.002. View

3.
Li J, Zheng S, Chen B, Butte A, Swamidass S, Lu Z . A survey of current trends in computational drug repositioning. Brief Bioinform. 2015; 17(1):2-12. PMC: 4719067. DOI: 10.1093/bib/bbv020. View

4.
Moum B, Ekbom A, Vatn M, Elgjo K . Change in the extent of colonoscopic and histological involvement in ulcerative colitis over time. Am J Gastroenterol. 1999; 94(6):1564-9. DOI: 10.1111/j.1572-0241.1999.01145.x. View

5.
Plevy S, Silverberg M, Lockton S, Stockfisch T, Croner L, Stachelski J . Combined serological, genetic, and inflammatory markers differentiate non-IBD, Crohn's disease, and ulcerative colitis patients. Inflamm Bowel Dis. 2013; 19(6):1139-48. PMC: 3792797. DOI: 10.1097/MIB.0b013e318280b19e. View